AI-generated synthetic real-world data to evaluate cancer treatment outcomes

Описание: Eddy Saad, MD, Beth Israel Deaconess Medical Center, Boston, MA, discusses the potential of an artificial intelligence (AI)-generated synthetic real-world data (sRWD) to provide real-world data on cancer treatment outcomes, enabling comparisons between standard of care and new regimens. This platform could facilitate the evaluation of new treatments and potentially reduce the resources required for clinical trials by providing a modern control arm. This interview took place at the European Society for Medical Oncology (ESMO) 2025 Congress in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.